Physician profile
Mary E Vadas
NPI 1285692103
$2,543.66
in general payments reported to CMS, 2019-2025
19 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $279 · 2021: $79.34 · 2022: $238 · 2023: $1,190 · 2024: $230 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $900 · Food and Beverage: $895 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $900.00 |
| Food and Beverage | $894.64 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,103.09 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Sight Sciences, INC. | $225.16 | 2020-2024 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $204.66 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $169.44 | 2023-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $149.00 | 2019-2023 | Cequa |
| Johnson & Johnson Vision Care, INC. | $107.03 | 2019-2024 | Acuvue |
| Lkc Technologies, INC. | $95.02 | 2022 | |
| Alcon Vision LLC | $87.24 | 2019-2025 | Precision 1, Precision7 |
| Novartis Pharmaceuticals Corporation | $76.35 | 2020-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $63.47 | 2019-2020 | |
| Carl Zeiss Meditec Ag | $58.20 | 2020 | |
| Oyster Point Pharma, INC. | $45.73 | 2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $34.29 | 2025 | Vevye |
| Maculogix, INC. | $27.83 | 2020-2021 | |
| Abbvie INC. | $23.90 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $22.35 | 2024 | Izervay |
| Shire North American Group INC | $20.16 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Allergan, INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Vadas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.